Physician profile
Bailey Phelps
NPI 1962846618
$1,078.17
in general payments reported to CMS, 2019-2025
16 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.90 · 2021: $77.82 · 2022: $204 · 2023: $197 · 2024: $224 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $344.20 | 2021-2025 | |
| Cvrx, INC. | $218.53 | 2025 | Barostim Neo System |
| Lilly USA, LLC | $103.73 | 2022-2024 | Mounjaro |
| Novo Nordisk INC | $82.53 | 2019-2023 | Wegovy |
| Amgen INC. | $71.58 | 2019-2023 | Prolia, Evenity |
| Pfizer INC. | $64.48 | 2021-2024 | |
| Phathom Pharmaceuticals, INC. | $49.76 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $30.18 | 2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $20.11 | 2021 | |
| Endogastric Solutions, INC | $15.98 | 2024 | Esophyx |
| Novartis Pharmaceuticals Corporation | $13.97 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.76 | 2022 | |
| Medtronic, INC. | $13.52 | 2025 | Endurant Iis |
| Glaxosmithkline, LLC. | $13.24 | 2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Allergan, INC. | $11.39 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bailey Phelps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.